Searchable abstracts of presentations at key conferences in endocrinology

ea0016oc4.9 | Bone and adrenal | ECE2008

Teriparatide (TPTD) treatment followed by either zoledronic acid (ZOL) 5 mg once yearly or strontium ranelate (SR) 2 g daily: preliminary results from the ZOSTER-Study

Riedmuller Gunter , Fahrleitner Astrid , Dobnig Harald , Piswanger Claudia , Stiegler Claudia , Stepan Vinzenz , Obermayer-Pietsch Barbara , Hans-Peter Dimai

Background: TPTD treatment has been shown to reduce vertebral and non-vertebral fracture risk in postmenopausal osteoporosis efficiently. However, gains in bone mass achieved by this treatment are almost lost 2 years after cessation of treatment, unless consecutively followed by an antiresorptive treatment such as alendronate.Subjects and methods: In the present prospective randomised open-labelled study in 52 pmp women, we investigated the effect of eit...

ea0056gp180 | Parathyroid | ECE2018

Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study

Clarke Bart L , Shoback Dolores M , Bilezikian John P , Bone Henry , Denham Douglas , Levine Michael A , Mannstadt Michael , Peacock Munro , Rothman Jeffrey , Vokes Tamara J , Warren Mark L , Watts Nelson B , Lee Hak-Myung , Sherry Nicole

Hypoparathyroidism is a disorder of mineral homoeostasis due to parathyroid hormone (PTH) deficiency. Conventional treatment with oral Ca and calcitriol may maintain serum Ca levels but does not replace other physiologic PTH effects. RACE is an ongoing open-label study of recombinant human PTH1-84 (rhPTH1-84) for hypoparathyroidism treatment in adults (ClinicalTrials.gov NCT01297309). Patients initially received rhPTH1-84 25 or 50 μg/day subcutaneously, with 25-μg in...

ea0029p454 | Clinical case reports - Thyroid/Others | ICEECE2012

Primary and secondary hyperparathyroidism coexisting in patient with liver cirrhosis and coeliac disease: efficiency of preoperative treatment with vitamin D

Swider G. , Orlowska-Florek R.

Introduction: Primary and secondary hyperparathyroidism may coexist unrelated to chronic nephropathy. It can occur more often than expected, especially in elderly population with malabsorption syndrome or /and liver diseases.Case report: A women 60 years of age was admitted to hospital due to long standing ostealgia. The primary hyperparathyroidism was suspected. The medical history presented recently diagnosed coeliac disease and cryptogenic hepatic cir...

ea0056p818 | Pituitary - Clinical | ECE2018

Diabetes insipidus due to hypothalamitis and infundibulo-neurohypophysitis

Oruk G Gonca , Apaydin Melda

Autoimmune hypothalamitis has been implicated in idiopathic central diabetes insipidus (DI) due to antibodies against vasopressin producing hypothalamic cells. Lymphocytic infiltration of hypothalamus has been reported in patients with lymphocytic hypophysitis (LH) manifesting as hypopituitarism with DI. These patients can also have other associated autoimmune diseases. Here, we report a case of a male patient who presented with headache, poor orientation, partial hypopituitar...

ea0081p208 | Thyroid | ECE2022

Estimating incidence and case fatality of thyroid storm in Germany between 2007 and 2017: A claims data analysis

Thiyagarajan Arulmani , Platzbecker Katharina , Ittermann Till , Volzke Henry , Haug Ulrike

Background: Given the general lack of descriptive epidemiological studies on thyroid storm, we aimed to estimate the incidence rate and case fatality of thyroid storm in Germany based on a large claims database.Methods: Using the German Pharmacoepidemiological Research Database (GePaRD) we identified patients with at least one inpatient discharge diagnosis of thyroid storm (International Statistical Classification of Diseases and Related Health Problems,...

ea0041ep275 | Clinical case reports - Pituitary/Adrenal | ECE2016

A novel case of hypomagnesaemia secondary to fludrocortisone

O'Connor Henry , Proske Doerthe , Batool Asma , Shakher Jayadave

We present a case of fludrocortisone-induced hypomagnesaemia in a 27-year old female with Autoimmune Polyglandular Syndrome Type1, manifesting as adrenal insufficiency, hypothyroidism and hypoparathyroidism. Her medications were; Alfalcidol 4 mcg; Levothyroxine 100 mcg; Hydrocortisone 20 mg bid; Fludrocortisone 200 mcg mane and 100 mcg nocte. The nocturnal dose of fludrocortisone was started 4 months prior to her presentation. She presented with a history of abdominal pain and...

ea0020oc3.4 | Reproduction/Stress/Endocrine Disruptors | ECE2009

Reference ranges for sex hormone-binding globulin and free testosterone index in adult men

Friedrich Nele , Volzke Henry , Krebs Alexander , Nauck Matthias , Wallaschofski Henri

Objective: The majority of circulating testosterone is bound to sex hormone-binding globulin (SHBG), but also to albumin and cortisol-binding globulin. The remaining part is free-circulating testosterone unattached to serum proteins, which represents the active form of the hormone. A common measurement of the free testosterone is the calculated free testosterone index (FTI)=100*(total testosterone/SHBG). Testosterone is the principal male sex hormone and is involved in the reg...

ea0020p86 | Thyroid | ECE2009

A comprehensive surgical approach of persistent cervical papillary thyroid carcinoma based on initial surgery and modern preoperative imaging modalities

Benmiloud Fares , Taieb David , Sebag Frederic , Henry Jean-Francois

Context: Reoperative surgery is the most efficient treatment of cervical persistent thyroid carcinoma. The extent of the surgery should be guided by the preoperative imaging findings, the primary surgery and the patient’s prognosis. However, there is no consensus concerning the optimal surgical strategy.Objective: Primary objective was to evaluate morbidity of a reoperative surgery. Secondary objectives were to evaluate performances of preoperative ...

ea0011p859 | Thyroid | ECE2006

Thyrotropin receptor (TSHR) activation has variable effects on the TNFα axis in preadipocyte and osteoblast-like cell lines

Mandrikoula M , Henry M , Evans BAJ , Ludgate M

In addition to its central role in the control of thyrocyte growth and function, the TSHR is expressed during the differentiation of mesenchymal precursors. To explore further, we have developed an in vitro model in which TSHR activation is achieved by introducing constitutively active (M453T, L629F) TSHR, using retroviral vectors.We aimed to investigate the effect of TSHR activation on body composition, via the production of TNFα and express...

ea0011p885 | Thyroid | ECE2006

Is subclinical hyperthyroidism associated with blood pressure and hypertension?

Völzke Henry , Dörr Marcus , Wallaschofski Henri

Objectives: While evidence for an increased risk of hypertension in both overt hyperthyroidism and overt hypothyroidism is consistent, the relation between subclinical hyperthyroidism and blood pressure has not yet received sufficient attention. We aimed to investigate possible associations of decreased serum thyrotropin levels and subclinical hyperthyroidism with blood pressure, pulse pressure, and the risk of hypertension.Design: The population-based c...